Helix BioMedix, Inc. (HXBM)
OTCMKTS
· Delayed Price · Currency is USD
7.18
-0.01 (-0.14%)
At close: Mar 5, 2025
Helix BioMedix Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | 2002 - 2006 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '12 Sep 30, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Dec '09 Dec 31, 2009 | Dec '08 Dec 31, 2008 | Dec '07 Dec 31, 2007 | 2002 - 2006 |
| Net Income | -2.58 | -2.49 | -7.71 | -3.78 | -4.52 | -3.43 | Upgrade
|
| Depreciation & Amortization | 0.09 | 0.11 | 0.11 | 0.13 | 0.13 | 0.17 | Upgrade
|
| Other Amortization | 0.11 | - | 0.21 | 0.08 | 0.83 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.01 | -0.01 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.04 | 0.09 | 0.07 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.2 | 0.15 | 0.19 | 0.1 | 0.31 | 0.16 | Upgrade
|
| Other Operating Activities | 0.01 | 0.01 | 4.46 | 0.49 | 0.2 | - | Upgrade
|
| Change in Accounts Receivable | 0.11 | -0.15 | -0.23 | -0.01 | 0.03 | -0.08 | Upgrade
|
| Change in Inventory | 0.03 | -0.09 | -0.08 | -0.09 | -0.05 | -0.07 | Upgrade
|
| Change in Accounts Payable | 0.25 | -0.01 | 0.06 | -0.01 | -0.02 | 0.03 | Upgrade
|
| Change in Unearned Revenue | -0.1 | 0.08 | 0.05 | - | -0.13 | 0.07 | Upgrade
|
| Change in Other Net Operating Assets | 0.02 | 0 | 0.06 | 0.01 | 0.06 | -0.06 | Upgrade
|
| Operating Cash Flow | -1.82 | -2.3 | -2.8 | -3.07 | -3.14 | -3.21 | Upgrade
|
| Capital Expenditures | -0.01 | -0 | -0.01 | -0.02 | -0.01 | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.02 | - | -0.03 | -0.02 | - | Upgrade
|
| Investment in Securities | -0.03 | -0.04 | -0.35 | - | 0.7 | 0.28 | Upgrade
|
| Other Investing Activities | - | - | - | 0.97 | -0.97 | - | Upgrade
|
| Investing Cash Flow | -0.03 | -0.06 | -0.36 | 0.93 | -0.3 | 0.25 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 0.97 | - | Upgrade
|
| Long-Term Debt Issued | - | - | 3.2 | 2.5 | 3 | - | Upgrade
|
| Total Debt Issued | - | - | 3.2 | 2.5 | 3.97 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.1 | - | - | - | Upgrade
|
| Total Debt Repaid | - | - | -0.1 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 3.1 | 2.5 | 3.97 | - | Upgrade
|
| Issuance of Common Stock | - | - | 2.75 | - | - | 2.14 | Upgrade
|
| Other Financing Activities | - | - | - | - | -0.01 | - | Upgrade
|
| Financing Cash Flow | - | - | 5.85 | 2.5 | 3.96 | 2.14 | Upgrade
|
| Net Cash Flow | -1.85 | -2.36 | 2.7 | 0.36 | 0.52 | -0.82 | Upgrade
|
| Free Cash Flow | -1.83 | -2.3 | -2.8 | -3.09 | -3.15 | -3.24 | Upgrade
|
| Free Cash Flow Margin | -88.57% | -121.54% | -329.02% | -789.38% | -560.37% | -698.14% | Upgrade
|
| Free Cash Flow Per Share | -11.04 | -13.87 | -30.99 | -36.12 | -36.89 | -38.65 | Upgrade
|
| Cash Interest Paid | - | - | 0.02 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -1.08 | -1.41 | -2.05 | -2.22 | -1.7 | -2 | Upgrade
|
| Unlevered Free Cash Flow | -1.13 | -1.41 | -1.71 | -1.94 | -1.88 | -2 | Upgrade
|
| Change in Net Working Capital | -0.1 | 0.15 | 0.16 | 0.12 | 0.09 | 0.11 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.